...Thank you, Mary, and good morning, everyone. We appreciate you joining us on the call today. I'm going to begin my remarks by highlighting our results for the fourth quarter and the full year. Later on in the call, Bob Kuhn, our CFO, will provide additional details on the quarter and year-end results. I will also spend some time talking about the strategic realignment that we announced in early December and the benefits we expect to achieve. Starting on Slide 3. For the fourth quarter, I'm pleased to report that Aptar achieved core sales growth of 4% and delivered adjusted EPS of $0.92 per share. We guided our adjusted earnings per share for the fourth quarter to be in the range of $0.73 to $0.83. The results were driven by strong volume growth in our Pharma segment, which continue to benefit from demand for nasal decongestions and saline rinses as well as allergic rhinitis and emergency medications. Solid volume growth from beauty dispensing solutions, especially in prestige fragrance...
